Rossari Biotech Ltd
Rossari Biotech was started in 2003. They are among the largest manufacturers of textile specialty chemicals in India. [1]
Their 3 main product categories are [2]:
- Home, personal care, and performance chemicals
- Textile specialty chemical
- Animal health and nutrition
The company has two R&D facilities, one at Silvassa manufacturing facility and a research lab at IIT Bombay. [3]
- Market Cap ₹ 4,016 Cr.
- Current Price ₹ 727
- High / Low ₹ 904 / 657
- Stock P/E 41.6
- Book Value ₹ 164
- Dividend Yield 0.07 %
- ROCE 11.7 %
- ROE 8.64 %
- Face Value ₹ 2.00
Pros
Cons
- Company has a low return on equity of 12.9% over last 3 years.
- Dividend payout has been low at 3.54% of profits over last 3 years
- Debtor days have increased from 75.1 to 91.3 days.
- Promoter holding has decreased over last 3 years: -4.37%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|
122 | 178 | 233 | 292 | 516 | 600 | 690 | 1,073 | 975 | 1,153 | |
108 | 166 | 209 | 247 | 438 | 495 | 569 | 950 | 853 | 998 | |
Operating Profit | 13 | 12 | 24 | 45 | 78 | 105 | 121 | 123 | 123 | 154 |
OPM % | 11% | 7% | 10% | 15% | 15% | 18% | 18% | 11% | 13% | 13% |
0 | 0 | 1 | 1 | 1 | 4 | 10 | 13 | 4 | 8 | |
Interest | 3 | 3 | 2 | 1 | 3 | 4 | 3 | 3 | 5 | 8 |
Depreciation | 5 | 4 | 4 | 5 | 12 | 17 | 22 | 26 | 26 | 24 |
Profit before tax | 6 | 5 | 19 | 39 | 63 | 88 | 106 | 107 | 96 | 130 |
Tax % | 11% | 29% | 17% | 27% | 28% | 26% | 25% | 26% | 25% | |
5 | 3 | 16 | 29 | 46 | 66 | 79 | 79 | 71 | 97 | |
EPS in Rs | 11.59 | 7.77 | 35.43 | 65.73 | 104.07 | 12.91 | 15.23 | 14.43 | 12.94 | 17.51 |
Dividend Payout % | 1% | 0% | 1% | 0% | 0% | 4% | 3% | 3% | 4% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 27% |
3 Years: | 18% |
TTM: | 18% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 20% |
3 Years: | 3% |
TTM: | 48% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -12% |
1 Year: | 6% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 16% |
3 Years: | 13% |
Last Year: | 9% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4 | 4 | 4 | 4 | 4 | 10 | 10 | 11 | 11 | 11 |
Reserves | 27 | 41 | 56 | 85 | 116 | 273 | 394 | 774 | 848 | 897 |
38 | 22 | 24 | 22 | 9 | 67 | 0 | 0 | 65 | 90 | |
24 | 37 | 37 | 49 | 119 | 118 | 140 | 141 | 202 | 258 | |
Total Liabilities | 93 | 104 | 122 | 160 | 248 | 468 | 544 | 926 | 1,126 | 1,255 |
43 | 36 | 37 | 44 | 74 | 94 | 171 | 177 | 155 | 152 | |
CWIP | 0 | 8 | 8 | 10 | 3 | 22 | 0 | 1 | 14 | 12 |
Investments | 0 | 0 | 0 | 3 | 0 | 15 | 9 | 381 | 493 | 515 |
50 | 60 | 77 | 103 | 171 | 338 | 364 | 367 | 463 | 576 | |
Total Assets | 93 | 104 | 122 | 160 | 248 | 468 | 544 | 926 | 1,126 | 1,255 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|
0 | 23 | 2 | 22 | 72 | 56 | 52 | 33 | 114 | |
0 | -5 | -6 | -16 | -41 | -187 | -37 | -318 | -161 | |
0 | -18 | 3 | -6 | -26 | 155 | -29 | 297 | 61 | |
Net Cash Flow | 0 | 1 | -0 | -1 | 5 | 23 | -14 | 12 | 14 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|
Debtor Days | 70 | 59 | 74 | 75 | 61 | 57 | 73 | 62 | 91 |
Inventory Days | 77 | 70 | 52 | 65 | 59 | 57 | 72 | 48 | 58 |
Days Payable | 83 | 79 | 70 | 71 | 114 | 95 | 100 | 51 | 93 |
Cash Conversion Cycle | 63 | 50 | 56 | 69 | 6 | 19 | 44 | 58 | 57 |
Working Capital Days | 78 | 42 | 54 | 66 | 24 | 38 | 61 | 63 | 63 |
ROCE % | 27% | 42% | 55% | 38% | 29% | 18% | 12% |
Documents
Announcements
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 12 Apr
- Board Meeting Outcome for Outcome Of The Board Meeting Held On April 06, 2024 6 Apr
-
Compliance Certificate Pursuant To Regulation 40(10)
5 Apr - Compliance Certificate issued by Mr. Sanjay Dholakia of Sanjay Dholakia & Associates, Practicing Company Secretaries, for the period April 01, 2023 to March 31, 2024.
- Compliance Certificate Under Regulation 7(3) Of SEBI (Listing And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2024. 4 Apr
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
4 Apr - Compliance certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018 for the quarter ended March 31, 2024.
Annual reports
Concalls
-
Jan 2024Transcript PPT
-
Oct 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
May 2022TranscriptNotesPPT
-
Feb 2022TranscriptNotesPPT
-
Oct 2021TranscriptNotesPPT
-
Aug 2021Transcript PPT
-
Jul 2021TranscriptPPT
-
Jun 2021TranscriptPPT
-
May 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Oct 2020Transcript PPT
-
Aug 2020Transcript PPT
Company Overview
Rossari Biotech is a Specialty-Chemicals manufacturer offering solutions for Home, Personal Care and Performance chemicals (HPPC), Textile specialty chemicals (TSC) and Animal Health and Nutrition (AHN). It offers a total of 4220+ products catering to an array of applications across FMCG, Home care, Industrial Cleaning, Personal Care, Textile, Performance Chemicals, Animal Health and Nutrition and Pet Care businesses. [1] [2]